Severe thrombocytopenia without major haemorrhage in dengue in a patient on dual antiplatelet therapy; a real world clinical experience

Key Points

• Investigate the management of thrombocytopenia in dengue patients on dual antiplatelet therapy.
• Analyzed cases of dengue presenting with thrombocytopenia while on antiplatelet therapy.
• Monitored for bleeding complications and patient outcomes.
• Assessed clinical decision-making regarding continued therapy.
• No major bleeding events recorded despite severe thrombocytopenia.
• Continued dual antiplatelet therapy was deemed safe in the observed cases.
• Patient outcomes showed resolution of dengue symptoms without major complications.